• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨质疏松症。

Osteoporosis.

机构信息

Warren Alpert Medical School of Brown University, Rhode Island Hospital, 593 Eddy St, Jane Brown Ground, Suite 0100, Providence, RI 02903, USA.

出版信息

Med Clin North Am. 2023 Mar;107(2):213-225. doi: 10.1016/j.mcna.2022.10.013. Epub 2023 Jan 5.

DOI:10.1016/j.mcna.2022.10.013
PMID:36759092
Abstract

Osteoporosis is the most common bone disease in adults and confers significant morbidity and mortality in women. Universal screening is recommended for women above the age of 65 years; however, screening rates remain low. Bisphosphonates are the treatment of choice despite a decline in their use due to concerns about rare side effects. Treatment of osteoporosis dramatically decreases the likelihood of fragility fractures.

摘要

骨质疏松症是成年人中最常见的骨骼疾病,会给女性带来严重的发病率和死亡率。建议对 65 岁以上的女性进行普遍筛查;然而,筛查率仍然很低。尽管由于对罕见副作用的担忧,双磷酸盐的使用有所减少,但它们仍是首选治疗方法。骨质疏松症的治疗可显著降低脆性骨折的可能性。

相似文献

1
Osteoporosis.骨质疏松症。
Med Clin North Am. 2023 Mar;107(2):213-225. doi: 10.1016/j.mcna.2022.10.013. Epub 2023 Jan 5.
2
The cost effectiveness of bisphosphonates for the prevention and treatment of osteoporosis: a structured review of the literature.双膦酸盐用于预防和治疗骨质疏松症的成本效益:文献的结构化综述
Pharmacoeconomics. 2007;25(11):913-33. doi: 10.2165/00019053-200725110-00003.
3
Underdiagnosis and under-treatment of osteoporosis following fragility fracture.脆性骨折后骨质疏松症的诊断不足与治疗不足。
Hawaii Med J. 2007 Jul;66(7):185-7.
4
Cost effectiveness of fracture prevention in postmenopausal women who receive aromatase inhibitors for early breast cancer.接受芳香化酶抑制剂治疗早期乳腺癌的绝经后妇女骨折预防的成本效益。
J Clin Oncol. 2012 May 1;30(13):1468-75. doi: 10.1200/JCO.2011.38.7001. Epub 2012 Feb 27.
5
Prevalence of bone mineral density testing and osteoporosis management following low- and high-energy fractures.低能量和高能量骨折后骨密度检测及骨质疏松症管理的患病率
Acta Orthop Traumatol Turc. 2013;47(5):318-22. doi: 10.3944/aott.2013.3065.
6
Bisphosphonates for osteoporosis in people with cystic fibrosis.双膦酸盐用于囊性纤维化患者的骨质疏松症治疗。
Cochrane Database Syst Rev. 2014 Mar 14;2014(3):CD002010. doi: 10.1002/14651858.CD002010.pub4.
7
Bisphosphonates for osteoporosis in people with cystic fibrosis.双膦酸盐用于囊性纤维化患者的骨质疏松症治疗。
Cochrane Database Syst Rev. 2012 Apr 18(4):CD002010. doi: 10.1002/14651858.CD002010.pub3.
8
Bisphosphonates for the prevention and treatment of osteoporosis.双膦酸盐类药物用于骨质疏松的预防和治疗。
BMJ. 2015 Sep 2;351:h3783. doi: 10.1136/bmj.h3783.
9
Bisphosphonates for osteoporosis in nonmetastatic prostate cancer patients receiving androgen-deprivation therapy: a systematic review and meta-analysis.双膦酸盐用于接受雄激素剥夺治疗的非转移性前列腺癌患者骨质疏松症:一项系统评价和荟萃分析。
Asian Pac J Cancer Prev. 2013;14(5):3337-43. doi: 10.7314/apjcp.2013.14.5.3337.
10
Menopausal osteoporosis: screening, prevention and treatment.更年期骨质疏松症:筛查、预防和治疗。
Singapore Med J. 2021 Apr;62(4):159-166. doi: 10.11622/smedj.2021036.

引用本文的文献

1
Integrating network pharmacology, IPA, and molecular docking to reveal the anti-osteoporosis effects of EA and EB via the FAK pathway.整合网络药理学、IPA和分子对接技术,以揭示EA和EB通过FAK通路产生的抗骨质疏松作用。
Front Pharmacol. 2025 Jul 2;16:1532665. doi: 10.3389/fphar.2025.1532665. eCollection 2025.
2
Piezoelectricity Regulating Immune Osteogenesis in Osteoporosis.压电效应调节骨质疏松症中的免疫性骨生成
BME Front. 2025 Jul 2;6:0146. doi: 10.34133/bmef.0146. eCollection 2025.
3
A disproportionality analysis of cardiac arrhythmia associated with bisphosphonates based on the FAERS database.
基于FAERS数据库的双膦酸盐类药物相关心律失常的不成比例性分析。
Sci Rep. 2025 Jul 1;15(1):20753. doi: 10.1038/s41598-025-00900-y.
4
SS-31 Targets NOS2 to Enhance Osteogenic Differentiation in Aged BMSCs by Restoring Mitochondrial Function.SS-31通过恢复线粒体功能靶向作用于一氧化氮合酶2以增强衰老骨髓间充质干细胞的成骨分化。
Organogenesis. 2025 Dec;21(1):2519649. doi: 10.1080/15476278.2025.2519649. Epub 2025 Jun 26.
5
Estradiol and vitamin D exert a synergistic effect on preventing osteoporosis via the miR-351-5p/IRS1 axis and mTOR/NFκB signaling pathway.雌二醇和维生素D通过miR-351-5p/IRS1轴和mTOR/NFκB信号通路对预防骨质疏松症发挥协同作用。
Sci Rep. 2025 May 28;15(1):18678. doi: 10.1038/s41598-025-02808-z.
6
Relationship between blood lipids and bone mineral density in healthy preschoolers: a 12-month cohort study.健康学龄前儿童血脂与骨密度的关系:一项为期12个月的队列研究。
J Pediatr Endocrinol Metab. 2025 May 22. doi: 10.1515/jpem-2024-0600.
7
Identification of senescence-related biomarkers for osteoporosis based on microarray analysis, Mendelian randomization, and experimental validation.基于微阵列分析、孟德尔随机化和实验验证的骨质疏松症衰老相关生物标志物的鉴定
Mamm Genome. 2025 May 24. doi: 10.1007/s00335-025-10116-0.
8
Association between depression and osteoporosis in a population of cancer survivors: results from the NHANES 2005-2020.癌症幸存者群体中抑郁症与骨质疏松症的关联:2005 - 2020年美国国家健康与营养检查调查结果
Front Med (Lausanne). 2025 Apr 22;12:1515435. doi: 10.3389/fmed.2025.1515435. eCollection 2025.
9
Harnessing engineered exosomes as METTL3 carriers: Enhancing osteogenesis and suppressing lipogenesis in bone marrow mesenchymal stem cells for postmenopausal osteoporosis treatment.利用工程化外泌体作为METTL3载体:增强骨髓间充质干细胞的成骨作用并抑制脂肪生成以治疗绝经后骨质疏松症
Mater Today Bio. 2025 Mar 20;32:101648. doi: 10.1016/j.mtbio.2025.101648. eCollection 2025 Jun.
10
Exosomal Manf originated from endothelium regulated osteoclast differentiation by down-regulating NF-κB signaling pathway.源自内皮细胞的外泌体Manf通过下调NF-κB信号通路调节破骨细胞分化。
J Orthop Surg Res. 2025 Apr 7;20(1):349. doi: 10.1186/s13018-025-05671-w.